Pollard AJ - Search Results

1

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.

Xie O, Bolgiano B, Gao F, Lockyer K, Swann C, Jones C, Delrieu I, Njanpop-Lafourcade BM, Tamekloe TA, Pollard AJ, Norheim G. Xie O, et al. Among authors: pollard aj. Vaccine. 2012 Aug 31;30(40):5812-23. doi: 10.1016/j.vaccine.2012.07.032. Epub 2012 Jul 24. Vaccine. 2012. PMID: 22835740

2

Development of natural immunity to Neisseria meningitidis.

Pollard AJ, Frasch C. Pollard AJ, et al. Vaccine. 2001 Jan 8;19(11-12):1327-46. doi: 10.1016/s0264-410x(00)00333-9. Vaccine. 2001. PMID: 11163654 Review.

3

Vaccine prevention of meningococcal disease, coming soon?

Morley SL, Pollard AJ. Morley SL, et al. Among authors: pollard aj. Vaccine. 2001 Dec 12;20(5-6):666-87. doi: 10.1016/s0264-410x(01)00410-8. Vaccine. 2001. PMID: 11738731 Review.

4

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America.

Pollard AJ, Ochnio J, Ho M, Callaghan M, Bigham M, Dobsong S. Pollard AJ, et al. Emerg Infect Dis. 2004 Oct;10(10):1812-5. doi: 10.3201/eid1010.040335. Emerg Infect Dis. 2004. PMID: 15504268 Free PMC article.

5

Meningococcal polysaccharide-protein conjugate vaccines.

Snape MD, Pollard AJ. Snape MD, et al. Among authors: pollard aj. Lancet Infect Dis. 2005 Jan;5(1):21-30. doi: 10.1016/S1473-3099(04)01251-4. Lancet Infect Dis. 2005. PMID: 15620558 Review.

6

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.

Snape MD, Kelly DF, Green B, Moxon ER, Borrow R, Pollard AJ. Snape MD, et al. Among authors: pollard aj. Pediatr Infect Dis J. 2005 Feb;24(2):128-31. doi: 10.1097/01.inf.0000151029.58752.27. Pediatr Infect Dis J. 2005. PMID: 15702040

7

Towards an improved serogroup B Neisseria meningitidis vaccine.

Perrett KP, Pollard AJ. Perrett KP, et al. Among authors: pollard aj. Expert Opin Biol Ther. 2005 Dec;5(12):1611-25. doi: 10.1517/14712598.5.12.1611. Expert Opin Biol Ther. 2005. PMID: 16318425 Review.

8

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

Kelly DF, Snape MD, Clutterbuck EA, Green S, Snowden C, Diggle L, Yu LM, Borkowski A, Moxon ER, Pollard AJ. Kelly DF, et al. Among authors: pollard aj. Blood. 2006 Oct 15;108(8):2642-7. doi: 10.1182/blood-2006-01-009282. Epub 2006 May 4. Blood. 2006. PMID: 16675705 Free article. Clinical Trial.

9

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants.

Ruggeberg JU, Collins C, Clarke P, Johnson N, Sinha R, Everest N, Chang J, Stanford E, Balmer P, Borrow R, Martin S, Robinson MJ, Moxon ER, Pollard AJ, Heath PT. Ruggeberg JU, et al. Among authors: pollard aj. Vaccine. 2007 Jan 4;25(2):264-71. doi: 10.1016/j.vaccine.2006.07.036. Epub 2006 Aug 4. Vaccine. 2007. PMID: 17070968

10

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.

Riddell A, Buttery JP, McVernon J, Chantler T, Lane L, Bowen-Morris J, Diggle L, Morris R, Lockhart S, Pollard AJ, Cartwright K, Moxon ER. Riddell A, et al. Among authors: pollard aj. Vaccine. 2007 May 10;25(19):3906-12. doi: 10.1016/j.vaccine.2007.01.097. Epub 2007 Feb 7. Vaccine. 2007. PMID: 17368663 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

755 results

Search Page